NULISA employs a sequential immunocomplex capture and release technique to improve the sensitivity of traditional proximity ...

The USA's proteomics market grows steadily, driven by NIH funding in personalized medicine, while Canada is expected to grow ...

Iowa State University scientists have made a significant breakthrough in scientists' ability to identify specific proteins ...

Illumina, Inc., a leader in DNA sequencing and array technologies, has launched a pilot proteomics program analyzing 50,000 ...

Multi-omics refers to an integrated approach that combines data from multiple "omics" technologies to provide a holistic ...

Platinum Pro is Quantum-Si’s newest Next-Generation Protein Sequencer™ built from the foundation of innovation established by ...

Illumina (ILMN) announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with deCODE Genetics, Standard ...

Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a pilot proteomics program to analyze 50,000 UK Biobank samples in collaboration with ...

Fourteen global pharma companies are getting together to conduct the largest proteomics study to date, analyzing 600,000 blood samples held in the UK Biobank to assess the levels of 5,400 different ...

Quantum-Si's NGPS technology disrupts protein analysis market, but recent equity raise and execution risks lead to Sell ...

A consortium of 14 pharmaceutical companies will now use those samples and start the largest proteomics study to date.